+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Artificial Insemination Market Report and Forecast 2023-2031

  • PDF Icon


  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805738
The global Artificial Insemination market value was USD 3 billion in 2022, driven by the increasing advancements in reproductive technologies across the globe. The market size is anticipated to grow at a CAGR of 9% during the forecast period of 2023-2031 to achieve a value of USD 6.5 billion by 2031.

Artificial Insemination: Introduction

Artificial insemination (AI) is a fertility treatment method that involves the introduction of sperm into the reproductive tract of a female for the purpose of achieving pregnancy. It is commonly used in both human and animal reproduction to overcome fertility challenges, such as low sperm count, decreased sperm motility, or anatomical issues. AI can be performed using various techniques, including intrauterine insemination (IUI) and in vitro fertilization (IVF).

Key Trends in the Artificial Insemination Market

Some key trends involved in the artificial insemination market are as follows:
  • Increasing demand for assisted reproductive technologies (ART): The demand for AI and other ART procedures is steadily growing due to factors such as delayed childbearing, rising infertility rates, and a growing acceptance of alternative family-building methods. The increasing awareness and accessibility of AI procedures have contributed to its popularity
  • Advancements in AI techniques and technologies: Technological advancements have led to improvements in AI procedures, including better sperm selection methods, cryopreservation techniques, and enhanced embryo culture systems. These advancements have increased the success rates of AI and improved overall outcomes for patients
  • Rising adoption of AI in animal breeding: AI is widely used in animal breeding programs to improve genetic traits, enhance breeding efficiency, and prevent the spread of genetic diseases. The use of AI in livestock, poultry, and other animal species has increased significantly, leading to improved breeding outcomes and genetic progress
  • Integration of AI with other reproductive technologies: AI is often combined with other reproductive technologies, such as preimplantation genetic testing (PGT) and embryo cryopreservation, to maximize the chances of a successful pregnancy. The integration of these technologies allows for comprehensive assessment and selection of viable embryos, increasing the success rates of AI procedures
  • Growing focus on personalized medicine and precision fertility treatments: The field of reproductive medicine is moving towards personalized approaches, where AI treatments are tailored to individual patient characteristics and needs. The use of genetic screening, advanced diagnostics, and personalized treatment plans based on patient-specific factors is gaining traction, leading to more targeted and effective AI treatments

Artificial Insemination Market Segmentations

Market Breakup by Type

  • Intrauterine Insemination
  • Intracervical Insemination
  • Intravaginal Insemination
  • Intratubal Insemination

Market Breakup by Product Type

  • Insemination Kits
  • Home Conception Devices
  • Accessories

Market Breakup by Source Type

  • AIH-Husband
  • Aid-Donor

Market Breakup by End User

  • Fertility Clinics
  • Hospitals
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Artificial Insemination Market Scenario

The market for artificial insemination (AI) has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, advancements in reproductive technologies, and a growing demand for alternative family-building methods. AI is widely used in both human and animal reproduction, offering a range of benefits and solutions for individuals and breeding programs.

In the human AI market, the demand for fertility treatments has been on the rise due to factors such as delayed childbearing, lifestyle choices, and medical conditions affecting fertility. AI provides a less invasive and more affordable option compared to other assisted reproductive technologies. The market has seen the emergence of specialized fertility clinics, advancements in sperm selection techniques, and improved success rates, contributing to its growth.

In the animal AI market, the adoption of AI techniques has become essential for breeding programs in livestock, poultry, and other animal species. AI allows for selective breeding, genetic improvement, and disease prevention. The market has witnessed the development of advanced semen collection and storage techniques, improved AI equipment, and increased availability of high-quality semen from superior sires.

Artificial Insemination Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Vitrolife Inc
  • Rinovum Women’s Health, Inc
  • Genea Ltd
  • Fujifilm Irvine Scientific, Inc
  • Pride Angel Ltd
  • Rocket Medical Plc
  • Conceivex, Inc
  • Hamilton Thorne, Inc
  • Nikon Instruments Inc
  • Zander scientific Inc
  • Kitazato Corporation
  • Biogenics Inc

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Artificial Insemination Market Overview
3.1 Global Artificial Insemination Market Historical Value (2016-2022)
3.2 Global Artificial Insemination Market Forecast Value (2023-2031)
4 Global Artificial Insemination Market Landscape
4.1 Global Artificial Insemination Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Artificial Insemination Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Product Type
4.2.3 Analysis by Source Type
4.2.4 Analysis by End User
5 Global Artificial Insemination Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Artificial Insemination Market Segmentation
6.1 Global Artificial Insemination Market by Type
6.1.1 Market Overview
6.1.2 Intrauterine Insemination
6.1.3 Intracervical Insemination
6.1.4 Intravaginal Insemination
6.1.5 Intratubal Insemination
6.2 Global Artificial Insemination Market by Product Type
6.2.1 Market Overview
6.2.2 Insemination Kits
6.2.3 Home Conception Devices
6.2.4 Accessories
6.3 Global Artificial Insemination Market by Source Type
6.3.1 Market Overview
6.3.2 AIH-Husband
6.3.3 Aid-Donor
6.4 Global Artificial Insemination Market by End User
6.4.1 Market Overview
6.4.2 Fertility Clinics
6.4.3 Hospitals
6.4.4 Others
6.5 Global Artificial Insemination Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Artificial Insemination Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Artificial Insemination Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Artificial Insemination Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Artificial Insemination Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Artificial Insemination Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Vitrolife Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Rinovum Women’s Health, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Genea Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Fujifilm Irvine Scientific, Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Pride Angel Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Rocket Medical Plc
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Conceivex, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Hamilton Thorne, Inc
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Nikon Instruments Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Zander scientific Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Kitazato Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Biogenics Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Artificial Insemination Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Vitrolife Inc.
  • Rinovum Women’s Health Inc.
  • Genea Ltd.
  • Fujifilm Irvine Scientific Inc.
  • Pride Angel Ltd.
  • Rocket Medical Plc
  • Conceivex Inc.
  • Hamilton Thorne Inc
  • Nikon Instruments Inc.
  • Zander scientific Inc.
  • Kitazato Corporation
  • Biogenics Inc.



Table Information